Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
M

Complication of AlloHSCT: Phases of Complications, Classification of GVHD, Ruxolitinib for SR Acute GVHD, Ibrutinib Induces Responses in SR Chronic GVH & Phases of Opportunistic Infections

By Memorial Sloan Kettering Cancer Center FEATURING Miguel-Angel Perales
By Memorial Sloan Kettering Cancer Center FEATURING Miguel-Angel Perales
324 views
March 25, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Hematologic Transplantation and Malignancies
11:20

ASH 2023 Insights: "Validation of the Composite CR Definitions in th…

Insights from 2023 ASH Annual Meeting

J. Bewersdorf

116 views
11:00

ASH 2022: Management of Accelerated and Blast-Phase MPN

ASH 2022 Conference Coverage

R. Rampal

61 views
23:13

MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…

MDS Foundation

E. Bernard

78 views
11:04

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …

ASH 2021 Conference Coverage on VuMedi

J. Bewersdorf

126 views
17:46

Which Published Schemas Are Helpful in MPN Transplant Decisions?

2021 International Congress on Myeloproliferative Neoplasms

S. Giralt

15 views
14:46

SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Schoenfeld

44 views
10:40

SOHO 2021: A Tumor-Agnostic TCR-Mimic CAR T-Cell Specific for NDC80 …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Klatt

27 views
11:24

2021 SOHO Highlights on CARs for Solid Tumors

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

R. O'Cearbhaill

6 views
24:52

CAR-T State of the Art: What Therapies Will Be Available in the Next…

SOHO Highlights: State of the Art and Next Questions

S. Giralt

40 views
18:48

2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Brentjens

135 views
16:23

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

R. Rampal

358 views
16:42

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of R…

University of Miami's 2nd Biennial Miami Leukemia Symposium

E. Stein

228 views
40:55

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and …

Memorial Sloan Kettering Cancer Center

M. Perales

46 views
23:23

Complication of AlloHSCT: Phases of Complications, Classification of…

Memorial Sloan Kettering Cancer Center

M. Perales

324 views
17:30

CNS Toxicity of CAR-T in Hematologic Malignancies: Clinical Manifest…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. Santomasso

19 views
65:45

Setting Up a CAR T Program Ins and Outs: Institutional Program Devel…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Giralt

33 views
23:38

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. Santomasso

32 views